Search Orphan Drug Designations and Approvals
-
| Generic Name: | AAV2.adalimumab |
|---|---|
| Date Designated: | 06/22/2022 |
| Orphan Designation: | Treatment of non-infectious intermediate, posterior, or panuveitis or chronic non-infectious anterior uveitis |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Kriya Therapeutics, Inc. 1219 Shiloh Glenn Dr Durham, North Carolina 27703 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







